Morphological and functional findings in COVID-19 lung disease as compared to Pneumonia, ARDS, and High-Altitude Pulmonary Edema

[1]  Hongxing Dang,et al.  Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data , 2022, Respiratory Research.

[2]  Arthur S Slutsky,et al.  Respiratory system mechanics, gas exchange, and outcomes in mechanically ventilated patients with COVID-19-related acute respiratory distress syndrome: a systematic review and meta-analysis , 2022, The Lancet Respiratory Medicine.

[3]  M. Singer,et al.  Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity , 2022, Intensive Care Medicine.

[4]  P. Pelosi,et al.  Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically effective therapeutics , 2022, Expert opinion on investigational drugs.

[5]  O. Sibila,et al.  High-Altitude Pulmonary Edema in the Context of COVID-19 , 2022, OBM Genetics.

[6]  Shota Yamamoto,et al.  ARDS Clinical Practice Guideline 2021 , 2022, Journal of Intensive Care.

[7]  Natalia Zubieta-DeUrioste,et al.  High Altitude Pulmonary Edema, High Altitude Cerebral Edema, and Acute Mountain Sickness: an enhanced opinion from the High Andes – La Paz, Bolivia 3,500 m , 2022, Reviews on environmental health.

[8]  T. Welte,et al.  Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19 , 2022, International journal of molecular sciences.

[9]  N. Sverzellati,et al.  Mechanisms of oxygenation responses to proning and recruitment in COVID-19 pneumonia , 2021, Intensive Care Medicine.

[10]  Xiao Yu,et al.  HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19 , 2021, Signal Transduction and Targeted Therapy.

[11]  Ali I. Al-Gareeb,et al.  The potential role of neopterin in Covid-19: a new perspective , 2021, Molecular and Cellular Biochemistry.

[12]  P. Pelosi,et al.  Coronavirus Disease 2019 Phenotypes, Lung Ultrasound, Chest Computed Tomography and Clinical Features in Critically Ill Mechanically Ventilated Patients , 2021, Ultrasound in Medicine & Biology.

[13]  P. Pelosi,et al.  Extension of Collagen Deposition in COVID-19 Post Mortem Lung Samples and Computed Tomography Analysis Findings , 2021, International journal of molecular sciences.

[14]  Natalia Zubieta-DeUrioste,et al.  The Oxygen Transport Triad in High-Altitude Pulmonary Edema: A Perspective from the High Andes , 2021, International journal of environmental research and public health.

[15]  P. Pelosi,et al.  Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study , 2021, Critical Care.

[16]  Marcelo Park,et al.  Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study , 2021, Annals of Intensive Care.

[17]  P. Saxena,et al.  Radiographical Spectrum of High-altitude Pulmonary Edema: A Pictorial Essay , 2021, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[18]  F. Bilotta,et al.  Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units , 2021, Critical Care.

[19]  D. Annane,et al.  Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis , 2021, Intensive Care Medicine.

[20]  A. Kotanidou,et al.  Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies , 2021, Critical Care.

[21]  P. Pelosi,et al.  Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19 , 2021, Expert review of respiratory medicine.

[22]  E. Clini,et al.  Spontaneous Breathing and Evolving Phenotypes of Lung Damage in Patients with COVID-19: Review of Current Evidence and Forecast of a New Scenario , 2021, Journal of clinical medicine.

[23]  P. Pelosi,et al.  Ten golden rules for individualized mechanical ventilation in acute respiratory distress syndrome , 2021, Journal of Intensive Medicine.

[24]  P. Pelosi,et al.  Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia , 2021, Critical Care.

[25]  P. Pelosi,et al.  Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies , 2021, Frontiers in Physiology.

[26]  I. Porto,et al.  Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review , 2021, Journal of clinical medicine.

[27]  I. Porto,et al.  Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 , 2020, Journal of geriatric cardiology : JGC.

[28]  R. Pardo-García,et al.  Histopathology features of the lung in COVID-19 patients , 2020, Diagnostic Histopathology.

[29]  M. Inglese,et al.  Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients , 2020, Frontiers in Neurology.

[30]  A. Fabro,et al.  Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians , 2020, Respiratory Medicine.

[31]  Yanfeng Wang,et al.  Hypoxia-Inducible Factor-1: A Potential Target to Treat Acute Lung Injury , 2020, Oxidative medicine and cellular longevity.

[32]  P. Pelosi,et al.  Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems , 2020, Virchows Archiv.

[33]  Natalia Zubieta-DeUrioste,et al.  Pneumolysis and “Silent Hypoxemia” in COVID-19 , 2020, Indian journal of clinical biochemistry : IJCB.

[34]  Kusal K. Das,et al.  COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view. , 2020, Reviews on recent clinical trials.

[35]  A. Engström‐Làurent,et al.  Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options? , 2020, The Journal of Biological Chemistry.

[36]  P. Pelosi,et al.  Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings , 2020, Frontiers in Neurology.

[37]  I. Berindan‐Neagoe,et al.  A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19 , 2020, Archives of Medical Research.

[38]  Ali I. Al-Gareeb,et al.  Renin–Angiotensin system and fibrinolytic pathway in COVID-19: One-way skepticism , 2020, Biomedical and Biotechnology Research Journal (BBRJ).

[39]  Sharon J Peacock,et al.  Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.

[40]  Pratik Sinha,et al.  Is a "Cytokine Storm" Relevant to COVID-19? , 2020, JAMA internal medicine.

[41]  P. Pelosi,et al.  Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2 , 2020, Expert review of respiratory medicine.

[42]  E. Vieta,et al.  Erythropoietin as candidate for supportive treatment of severe COVID-19 , 2020, Molecular medicine.

[43]  R. Dhingra,et al.  Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? , 2020, Respiratory Physiology & Neurobiology.

[44]  M. Aepfelbacher,et al.  Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany , 2020, International Journal of Legal Medicine.

[45]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[46]  P. Pelosi,et al.  Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 , 2020, Respiratory Physiology & Neurobiology.

[47]  M. Aepfelbacher,et al.  Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.

[48]  G. Li Volti,et al.  COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy! , 2020, Journal of clinical medicine.

[49]  M. Dutschmann,et al.  Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude? , 2020, Respiratory Physiology & Neurobiology.

[50]  P. Mitra,et al.  COVID-19 Pandemic in India: What Lies Ahead , 2020, Indian Journal of Clinical Biochemistry.

[51]  L. Camporota,et al.  COVID-19 pneumonia: different respiratory treatments for different phenotypes? , 2020, Intensive Care Medicine.

[52]  Amber Dance.  What is a cytokine storm? , 2020 .

[53]  Subha Ghosh,et al.  COVID-19 Autopsies, Oklahoma, USA , 2020, American journal of clinical pathology.

[54]  Kasra Kolahdouzan,et al.  Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects? , 2020, Journal of medical virology.

[55]  S. Rees,et al.  Changes in shunt, ventilation/perfusion mismatch, and lung aeration with PEEP in patients with ARDS: a prospective single-arm interventional study , 2020, Critical Care.

[56]  B. Hanley,et al.  Autopsy in suspected COVID-19 cases , 2020, Journal of Clinical Pathology.

[57]  Qiang Zhou,et al.  Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.

[58]  J. Newman,et al.  Vascular homeostasis at high-altitude: role of genetic variants and transcription factors , 2020, Pulmonary circulation.

[59]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[60]  J. González-Martín,et al.  Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. , 2020, The Lancet. Respiratory medicine.

[61]  W. Cao,et al.  Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia , 2020, Emerging microbes & infections.

[62]  V. Modesto,et al.  El lado oculto de la hipoxemia , 2020, Revista Chilena de Anestesia.

[63]  D. Ivy,et al.  High Altitude Pulmonary Edema in Children: A Single Referral Center Evaluation. , 2019, The Journal of pediatrics.

[64]  M. Gladwin,et al.  Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases , 2018, European Respiratory Journal.

[65]  Yansheng Du,et al.  The plasma level changes of VEGF and soluble VEGF receptor-1 are associated with high-altitude pulmonary edema. , 2018, The journal of medical investigation : JMI.

[66]  P. Cardinal-Fernández,et al.  What every intensivist should know about acute respiratory distress syndrome and diffuse alveolar damage , 2017, Revista Brasileira de terapia intensiva.

[67]  J. Lorente,et al.  Acute Respiratory Distress Syndrome and Diffuse Alveolar Damage. New Insights on a Complex Relationship. , 2017, Annals of the American Thoracic Society.

[68]  A. Agrawal,et al.  Raised HIF1α during normoxia in high altitude pulmonary edema susceptible non-mountaineers , 2016, Scientific Reports.

[69]  A. Chawla,et al.  Objective criteria for diagnosing high altitude pulmonary edema in acclimatized patients at altitudes between 2700 m and 3500 m. , 2015, Medical journal, Armed Forces India.

[70]  H. Ghofrani,et al.  Pathophysiology and Treatment of High-Altitude Pulmonary Vascular Disease , 2015, Circulation.

[71]  B. Souweine,et al.  Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management , 2015, Intensive Care Medicine.

[72]  R. Glenny,et al.  Gas exchange and ventilation–perfusion relationships in the lung , 2014, European Respiratory Journal.

[73]  C. Vancheri,et al.  Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): a pictorial review , 2014, Insights into Imaging.

[74]  Shandra L. Protzko,et al.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.

[75]  T. Franquet,et al.  Recommendations of SEPAR Guidelines for the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis , 2015 .

[76]  J. Kanne,et al.  Acute pulmonary injury: high-resolution CT and histopathological spectrum. , 2013, The British journal of radiology.

[77]  Ó. Peñuelas,et al.  Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. , 2013, American journal of respiratory and critical care medicine.

[78]  S. Mukhopadhyay,et al.  Acute Interstitial Pneumonia (AIP): Relationship to Hamman-Rich Syndrome, Diffuse Alveolar Damage (DAD), and Acute Respiratory Distress Syndrome (ARDS) , 2012, Seminars in Respiratory and Critical Care Medicine.

[79]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[80]  A. Loeckinger,et al.  Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia. , 2012, Wilderness & environmental medicine.

[81]  D. Hansell,et al.  Changes in lung composition and regional perfusion and tissue distribution in patients with ARDS , 2011, Respirology.

[82]  H. Iwanaga,et al.  Characteristic crescentic subpleural lung zones with high ventilation (V)/perfusion (Q) ratios in interstitial pneumonia on V/Q quotient SPECT , 2009, Nuclear medicine communications.

[83]  A. Medford,et al.  Vascular endothelial growth factor receptor and coreceptor expression in human acute respiratory distress syndrome , 2009, Journal of critical care.

[84]  J. West.  Tolerance to hypoxia. , 2009, High altitude medicine & biology.

[85]  P. Pelosi,et al.  Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality? , 2008, Current opinion in critical care.

[86]  Derliz Mereles,et al.  Magnetic resonance imaging of uneven pulmonary perfusion in hypoxia in humans. , 2006, American journal of respiratory and critical care medicine.

[87]  J. Penninger,et al.  Angiotensin-converting enzyme 2 in lung diseases , 2006, Current Opinion in Pharmacology.

[88]  A. Verin,et al.  Neuropilin-1 Regulates Vascular Endothelial Growth Factor–Mediated Endothelial Permeability , 2005, Circulation research.

[89]  W. Zin,et al.  Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. , 2005, Journal of applied physiology.

[90]  D. Levin,et al.  Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. , 2005, American journal of respiratory and critical care medicine.

[91]  K. Plate,et al.  Vascular endothelial growth factor , 1997, Journal of Neuro-Oncology.

[92]  P. Pelosi,et al.  Pulmonary and extrapulmonary acute respiratory distress syndrome are different , 2003, European Respiratory Journal.

[93]  S. Raiden,et al.  Nonpeptide Antagonists of AT1 Receptor for Angiotensin II Delay the Onset of Acute Respiratory Distress Syndrome , 2002, Journal of Pharmacology and Experimental Therapeutics.

[94]  S. Humphries,et al.  Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. , 2002, American journal of respiratory and critical care medicine.

[95]  S. Raiden,et al.  Nonpeptide Antagonists of AT 1 Receptor for Angiotensin II Delay the Onset of Acute Respiratory Distress Syndrome , 2002 .

[96]  L. Goodman,et al.  What has computed tomography taught us about the acute respiratory distress syndrome? , 2001, American journal of respiratory and critical care medicine.

[97]  T. Honda,et al.  Pathological features of the lung in fatal high altitude pulmonary edema occurring at moderate altitude in Japan. , 2001, High altitude medicine & biology.

[98]  L. Goodman,et al.  Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical, and functional correlations. , 1999, Radiology.

[99]  D. Hansell,et al.  Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. , 1999, Radiology.

[100]  I. Nishio,et al.  [Angiotensin I converting enzyme]. , 1999, Nihon rinsho. Japanese journal of clinical medicine.

[101]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 , 1998 .

[102]  M. von Albertini,et al.  High-altitude pulmonary edema. , 1996, The New England journal of medicine.

[103]  P. Pelosi,et al.  Lung structure and function in different stages of severe adult respiratory distress syndrome. , 1994, JAMA.

[104]  P. Pelosi,et al.  Vertical gradient of regional lung inflation in adult respiratory distress syndrome. , 1994, American journal of respiratory and critical care medicine.

[105]  J. Hogg.  Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.

[106]  N. Müller,et al.  Acute interstitial pneumonia: radiographic and CT findings in nine patients. , 1993, Radiology.

[107]  G. Zubieta-Calleja.  High altitude pathology at 12000 ft. , 1989 .

[108]  J. Timmes,et al.  Open lung biopsy. , 1967, Surgery.

[109]  J. Severinghaus,et al.  PULMONARY BLOOD FLOW , 1958 .

[110]  L. Hall.  Pneumolysis in the Treatment of Pulmonary Tuberculosis , 1938 .